Orsini Becomes a Specialty Pharmacy Provider for SAJAZIR™
Orsini has recently stepped into a significant role as a specialty pharmacy provider for SAJAZIR™ (icatibant) Injection. This innovative treatment is designed to address acute attacks of hereditary angioedema (HAE) in adults aged 18 and older. The addition of SAJAZIR makes it the ninth therapy focused on HAE integrated into Orsini's established Allergy and Immunology Center of Excellence, showcasing the company's ongoing commitment to addressing rare diseases.
Understanding Hereditary Angioedema and its Challenges
Hereditary angioedema is a genetic disorder that can severely affect the immune system, leading to unpredictable episodes of significant swelling in various body parts, including the limbs, face, intestines, and airways. These distressing attacks can be triggered by stress or minor injuries, but often they occur without any identifiable reason. One notable feature of SAJAZIR is that patients can administer it themselves upon recognizing the onset of an attack, offering them greater autonomy over their treatment.
Dedicated Support for Patients
Orsini's commitment extends beyond just providing medication; the company boasts a dedicated HAE Care Team and collaborates closely with Cycle Pharmaceuticals’ patient support program, Cycle Vita™. This partnership ensures that patients receive not only medication but also comprehensive support tailored to their unique challenges.
Leadership Perspective on the Partnership
Brandon Tom, the CEO of Orsini, expressed enthusiasm about this new offering: "It's been Orsini's honor to offer care to HAE patients and their families for over 13 years. Our experience has given us insights into the unique challenges these patients face daily. We are excited to work alongside Cycle Pharmaceuticals to expand our services and provide SAJAZIR to the HAE community. This collaboration enriches our portfolio and enhances our commitment to patient care."
About Orsini Specialty Pharmacy
Founded in 1987, Orsini has made significant strides in providing compassionate care to patients dealing with rare diseases and complex health conditions. The company has established a name for itself in the realm of rare diseases and gene therapies, partnering with biopharmaceutical innovators and health care professionals to facilitate access to advanced treatments.
Comprehensive Care Models
Orsini employs an integrated care model that simplifies patient access to innovative therapies. Their offerings include pharmacy distribution, patient services, and clinical management. With a personalized approach to care, the company emphasizes high-touch services delivered by expert therapy care teams, ensuring that no patient is left behind. Furthermore, Orsini has received prestigious accreditations, including from the Accreditation Commission for Health Care (ACHC) and URAC.
Ensuring Quality and Excellence
Orsini Specialty Pharmacy holds several accreditations, reflecting its dedication to quality care. Notably, it has earned URAC's designation as a Rare Disease Pharmacy Center of Excellence and ACHC's distinction in rare diseases and orphan drugs. As part of its mission, Orsini continues to strive for excellence in meeting the needs of its patients with a focus on providing revolutionary treatments.
About Cycle Pharmaceuticals
Cycle Pharmaceuticals, established in 2012, focuses on addressing the unmet needs of patients with rare diseases through innovative medication and support programs. The company is particularly dedicated to treating rare metabolic, immunological, and neurological conditions, including multiple sclerosis. Cycle has built a reputation for its commitment to making essential treatments available to patients who need them the most.
Frequently Asked Questions
What is SAJAZIR used for?
SAJAZIR is used for treating acute attacks of hereditary angioedema in adults, allowing self-administration for the patients when they recognize the onset of an attack.
How does Orsini support HAE patients?
Orsini provides dedicated care through a specialized HAE Care Team and collaborates with Cycle Pharmaceuticals’ Cycle Vita™ program to ensure comprehensive support for patients.
What makes hereditary angioedema challenging?
HAE is characterized by unpredictable episodes of severe swelling, which can be triggered by various factors, complicating management for patients.
What other therapies does Orsini offer?
Orsini’s Allergy and Immunology Center provides several therapies for rare diseases, enhancing its commitment to patient care in this area.
How can patients contact Orsini for more information?
Patients can reach Orsini directly at 847-734-7373 ext. 505 or visit www.orsinispecialtypharmacy.com for more information.
